.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Ayrloom is stocked at 415 licensed dispensaries across New York, Connecticut, and 3 other states, 409 of them in New York, with the deepest coverage in New York, Buffalo, Queens, Rochester, and Syracuse. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Ayrloom’s August 2026 mix tilted toward Vapor Pens at 37.03% share with year-over-year decline of 21.94% and month-over-month decline of 4.43%, while Beverage held 22.30% share with year-over-year decline of 9.46% and month-over-month decline of 5.26%. Pre-Roll expanded to 14.48% share with year-over-year growth of 8.39% and month-over-month growth of 1.24%, and Tincture & Sublingual reached 9.23% share with year-over-year growth of 5.15% and month-over-month growth of 3.29%. Edible contracted to 13.93% share with year-over-year decline of 18.74% and month-over-month decline of 5.17%, while Topical represented 3.02% share with year-over-year decline of 5.07% but month-over-month growth of 4.69%. The pattern implies a pivot from inhalables-led volume to a more balanced portfolio, with gains in Pre-Roll and Tincture & Sublingual partially offsetting Vapor Pens and Edible softness.
With brand sales down 12.69% year over year alongside a 9.61% decline in average price, the combination of shrinking Vapor Pens and Edible and expanding Pre-Roll and Tincture & Sublingual indicates trade-down and format diversification rather than pure demand erosion. Maintaining a number 3 rank in Vapor Pens in New York while that category fell 21.94% year over year and 4.43% month over month suggests reliance on a leader category that is compressing, making the 8.39% year-over-year growth in Pre-Roll and 5.15% in Tincture & Sublingual critical to stabilize mix. The implication is to lean into growth pockets where month-over-month gains of 1.24% and 3.29% signal momentum, while using pricing architecture in Vapor Pens and Edible to slow the 5.17% to 5.26% month-over-month pullback and protect share.
Competitive Landscape
Ayrloom sits at rank #3 in New York Vapor Pens in August 2026, down 1 place year over year from #2, with no change versus three months ago at #3; this sits below its peak at #1 in December 2024 and above Mfny (Marijuana Farms New York) at #4, while Fernway advanced from #3 to #1 and Jaunty slipped from #1 to #2 alongside a -24.3% sales change, contrasting Fernway’s +35.5% gain; Ayrloom’s flat three-month rank at #3 against Jetty Extracts rising from #26 to #5 on +228.2% sales indicates a squeeze from faster climbers above and below, implying Ayrloom’s trajectory points to share defense rather than recovery without a catalyst.
Notable Products
CBD/THC 1:2 Up Honeycrisp Apple Cider (5mg CBD, 10mg THC, 12oz) posted a 6.8% month-over-month increase in August 2026 while holding rank 1, as CBD/THC 1:2 Half & Half Lemonade Iced Tea UP (5mg CBD, 10mg THC, 12oz) slipped 2.7% at rank 2. Across the top ten, five SKUs between ranks 1 and 5 declined between 0.9% and 5.7%, and Black Cherry Sparkling Water fell 8.1% at rank 8; the pattern implies share consolidation around a single flagship rather than broad-based momentum.
CBD/THC 1:2 Orange Creamsicle Up Soda (5mg CBD, 10mg THC, 355ml, 12oz) dropped 5.7% at rank 3 as Vanilla Cola in rank 7 grew 1.2%, and the CBC/THC 1:1 Rosé Sparkling Dry Cider at rank 9 contracted 5.4%. With nine of the top ten in Beverage and one SKU without a prior-month baseline at rank 10, the category concentration points to a beverage-led portfolio that depends on flavor rotation to offset mid-pack softness, with the Honeycrisp Apple Cider’s approximately $208,000 anchoring mix and signaling a tilt toward cider-forward formulations.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
